Clinicopathological analysis of patients with molecularly confirmed stage I adult granulosa cell tumors and prediction of recurrence.

[1]  J. Sehouli,et al.  Adult ovarian granulosa cell tumors: analysis of outcomes and risk factors for recurrence , 2023, International Journal of Gynecological Cancer.

[2]  C. Genestie,et al.  Estradiol promotes cell survival and induces Greb1 expression in granulosa cell tumors of the ovary through an ERα‐dependent mechanism , 2021, The Journal of pathology.

[3]  N. Bradshaw,et al.  A phase 2 study of anastrozole in patients with oestrogen receptor and/progesterone receptor positive recurrent/metastatic granulosa cell tumours/sex-cord stromal tumours of the ovary: The PARAGON/ANZGOG 0903 trial. , 2021, Gynecologic oncology.

[4]  Yi Kan Wang,et al.  Adult‐type granulosa cell tumor of the ovary: a FOXL2‐centric disease , 2021, The journal of pathology. Clinical research.

[5]  R. Verheijen,et al.  Whole Genome Analysis of Ovarian Granulosa Cell Tumors Reveals Tumor Heterogeneity and a High-Grade TP53-Specific Subgroup , 2020, Cancers.

[6]  H. Horlings,et al.  Functional Profiling of FSH and Estradiol in Ovarian Granulosa Cell Tumors , 2020, Journal of the Endocrine Society.

[7]  S. Singhal,et al.  A clinicopathological study of granulosa cell tumors of the ovary: Can morphology predict prognosis? , 2020, Indian journal of pathology & microbiology.

[8]  A. Badran,et al.  Adult-type ovarian granulosa cell tumour: Treatment Outcomes from a Single Institutional Experience , 2019 .

[9]  I. Soubeyran,et al.  Adult Granulosa Cell Tumor With High-grade Transformation , 2019, The American journal of surgical pathology.

[10]  E. Taylan,et al.  Does lymphadenectomy effect postoperative surgical morbidity and survival in patients with adult granulosa cell tumor of ovary? , 2019, The journal of obstetrics and gynaecology research.

[11]  J. Edwards,et al.  The association between progesterone receptor expression and survival in women with adult granulosa cell tumors. , 2019, Gynecologic oncology.

[12]  E. Babarović,et al.  Adult Granulosa Cell Tumors of the Ovary: A Retrospective Study of 36 FIGO Stage I Cases with Emphasis on Prognostic Pathohistological Features , 2018, Analytical cellular pathology.

[13]  G. Scambia,et al.  Estrogen receptor β: Potential target for therapy in adult granulosa cell tumors? , 2018, Gynecologic oncology.

[14]  N. Chraiet,et al.  Granulosa Cell Tumor of the Ovary: A Retrospective Study of 31 Cases and a Review of the Literature , 2018, International journal of surgical oncology.

[15]  M. Arvas,et al.  Endogenous c-Jun N-terminal kinase (JNK) activity marks the boundary between normal and malignant granulosa cells , 2018, Cell Death & Disease.

[16]  Jia-xin Yang,et al.  Clinicopathological characteristics and prognosis of adult ovarian granulosa cell tumor: a single-institution experience in China , 2018, OncoTargets and therapy.

[17]  Robert Morris,et al.  Granulosa Cell Tumors: Novel Predictors of Recurrence in Early-stage Patients , 2017, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

[18]  Kiyong Na,et al.  Stromal p16 Overexpression in Adult Granulosa Cell Tumors of the Ovary. , 2017, Anticancer research.

[19]  J. Tapper,et al.  Characteristics and outcome of recurrence in molecularly defined adult-type ovarian granulosa cell tumors. , 2016, Gynecologic oncology.

[20]  A. Talhouk,et al.  Molecularly Defined Adult Granulosa Cell Tumor of the Ovary: The Clinical Phenotype. , 2016, Journal of the National Cancer Institute.

[21]  Georgios Vlachos,et al.  Prognostic factors for recurrence in early stage adult granulosa cell tumor of the ovary , 2016, Archives of Gynecology and Obstetrics.

[22]  G. Tulunay,et al.  Prognostic Factors in Adult Granulosa Cell Tumor: A Long Follow-Up at a Single Center , 2016, International Journal of Gynecologic Cancer.

[23]  G. Kenter,et al.  Evaluation of response to hormone therapy in patients with measurable adult granulosa cell tumors of the ovary , 2015, Acta obstetricia et gynecologica Scandinavica.

[24]  A. Shelling,et al.  Stage I granulosa cell tumours: A management conundrum? Results of long-term follow up. , 2015, Gynecologic oncology.

[25]  Y. Ojima,et al.  Aggressive Granulosa Cell Tumor of the Ovary with Rapid Recurrence: a Case Report and Review of the Literature. , 2015, The Kobe journal of medical sciences.

[26]  M. Anttonen,et al.  Clinical Characteristics and Survival of Patients With an Adult-Type Ovarian Granulosa Cell Tumor: A 56-Year Single-Center Experience , 2015, International Journal of Gynecologic Cancer.

[27]  H. Horlings,et al.  Development and internal validation of a prognostic model to predict recurrence free survival in patients with adult granulosa cell tumors of the ovary. , 2014, Gynecologic oncology.

[28]  N. Kayani,et al.  Recurrence of adult granulosa cell tumor of the ovary: experience at a tertiary care center. , 2014, Annals of diagnostic pathology.

[29]  Soon‐Beom Kang,et al.  A Long-term follow-up study of 91 cases with ovarian granulosa cell tumors. , 2014, Anticancer research.

[30]  Jaime Prat,et al.  Staging classification for cancer of the ovary, fallopian tube, and peritoneum , 2014, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[31]  D. Doherty,et al.  β‐Catenin and E‐cadherin expression in stage I adult‐type granulosa cell tumour of the ovary: correlation with tumour morphology and clinical outcome , 2013, Histopathology.

[32]  C. Stewart,et al.  Immunohistochemical expression and prognostic significance of oestrogen receptor-alpha, oestrogen receptor-beta, and progesterone receptor in stage 1 adult-type granulosa cell tumour of the ovary , 2012, Pathology.

[33]  Mu‐Hsien Yu,et al.  A long-term follow-up study of 176 cases with adult-type ovarian granulosa cell tumors. , 2012, Gynecologic oncology.

[34]  S. Nofech-Mozes,et al.  Immunohistochemical Characterization of Primary and Recurrent Adult Granulosa Cell Tumors , 2012, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

[35]  M. Grabiec,et al.  Bilateral aggressive malignant granulosa cell tumour with essentially different immunophenotypes in primary and metastatic lesions comprising predominantly sarcomatoid and fibrothecomatous patterns – looking for prognostic markers: a case report , 2011, Archives of medical science : AMS.

[36]  R. Young,et al.  Ovarian sex cord-stromal tumours and their mimics. , 2018, Pathology.